社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
ahoon
IP属地：未知
+关注
帖子 · 64
帖子 · 64
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
ahoon
ahoon
·
2021-12-29
Good 👍
Novavax Shares Jumped 3% in Morning Trading
Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.
Novavax Shares Jumped 3% in Morning Trading
看
1,385
回复
1
点赞
6
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-22
Ok
Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.
Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%. Pfizer
Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.
看
1,041
回复
评论
点赞
3
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-17
Ok
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron
看
981
回复
评论
点赞
3
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-16
👍
After a dazzling 2021, Apple and Tesla stocks are expected to be duds in 2022
Here’s the outlook for the 25 stocks that have contributed more than half of the S&P 500 index’s gai
After a dazzling 2021, Apple and Tesla stocks are expected to be duds in 2022
看
1,308
回复
评论
点赞
2
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-14
Great
Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%
Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove
Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%
看
1,384
回复
1
点赞
2
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-09
Keep going 👍
Apple shares rose nearly 2% to a new high
Apple shares rose nearly 2% to a new high in morning trading.
Apple shares rose nearly 2% to a new high
看
1,544
回复
1
点赞
2
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-08
Up and down
Some Vaccine stocks corrected in premarket trading
Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell betwe
Some Vaccine stocks corrected in premarket trading
看
1,470
回复
评论
点赞
3
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-07
Great 👍
Stocks linked to the reopening of the economy gained on Monday
Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book
Stocks linked to the reopening of the economy gained on Monday
看
1,256
回复
评论
点赞
1
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-02
🤔
Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?
Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks
Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?
看
1,916
回复
评论
点赞
1
编组 21备份 2
分享
举报
ahoon
ahoon
·
2021-12-01
Hopefully both vaccine can work
Moderna stock slid 1.5% in premarket trading
Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective agai
Moderna stock slid 1.5% in premarket trading
看
1,478
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4087362605261610","uuid":"4087362605261610","gmtCreate":1624259542457,"gmtModify":1624259542457,"name":"ahoon","pinyin":"ahoon","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":15,"headSize":2,"tweetSize":64,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696271604,"gmtCreate":1640711237953,"gmtModify":1640711238173,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Good 👍","listText":"Good 👍","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696271604","repostId":"1150918555","repostType":4,"repost":{"id":"1150918555","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640702663,"share":"https://www.laohunote.com/m/news/1150918555?lang=&edition=full","pubTime":"2021-12-28 22:44","market":"us","language":"en","title":"Novavax Shares Jumped 3% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1150918555","media":"Tiger Newspress","summary":"Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.","content":"<p>Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/d7f50d71385e7262972c51f222a641a6\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Shares Jumped 3% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Shares Jumped 3% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/d7f50d71385e7262972c51f222a641a6\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150918555","content_text":"Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1385,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691938103,"gmtCreate":1640115497938,"gmtModify":1640115498159,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691938103","repostId":"1148529089","repostType":4,"repost":{"id":"1148529089","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640098401,"share":"https://www.laohunote.com/m/news/1148529089?lang=&edition=full","pubTime":"2021-12-21 22:53","market":"us","language":"en","title":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1148529089","media":"Tiger Newspress","summary":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\nPfizer","content":"<p>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.</p>\n<p>Pfizer fell more than 5%, Novavax fell nearly 10%.<img src=\"https://static.tigerbbs.com/8965c7ba2ab9d4149e37dd1a91113e13\" tg-width=\"717\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-21 22:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.</p>\n<p>Pfizer fell more than 5%, Novavax fell nearly 10%.<img src=\"https://static.tigerbbs.com/8965c7ba2ab9d4149e37dd1a91113e13\" tg-width=\"717\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148529089","content_text":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\nPfizer fell more than 5%, Novavax fell nearly 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1041,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690569571,"gmtCreate":1639693713607,"gmtModify":1639693713827,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690569571","repostId":"1108384523","repostType":4,"repost":{"id":"1108384523","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639667369,"share":"https://www.laohunote.com/m/news/1108384523?lang=&edition=full","pubTime":"2021-12-16 23:09","market":"us","language":"en","title":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=1108384523","media":"Tiger Newspress","summary":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a","content":"<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). </p>\n<p>A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. </p>\n<p>Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). </p>\n<p>Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). </p>\n<p>A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. </p>\n<p>Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). </p>\n<p>Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108384523","content_text":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). \nA significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. \nResearchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). \nData demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.","news_type":1},"isVote":1,"tweetType":1,"viewCount":981,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690397164,"gmtCreate":1639630514950,"gmtModify":1639630515181,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690397164","repostId":"2191399540","repostType":4,"repost":{"id":"2191399540","kind":"highlight","pubTimestamp":1639624268,"share":"https://www.laohunote.com/m/news/2191399540?lang=&edition=full","pubTime":"2021-12-16 11:11","market":"us","language":"en","title":"After a dazzling 2021, Apple and Tesla stocks are expected to be duds in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2191399540","media":"MarketWatch","summary":"Here’s the outlook for the 25 stocks that have contributed more than half of the S&P 500 index’s gai","content":"<p>Here’s the outlook for the 25 stocks that have contributed more than half of the S&P 500 index’s gain this year</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c7f9d26b6e333f1a0e3ef46a61239eb7\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>Shares of Apple have returned 32% this year, while Tesla has risen 36%. Getty Images</span></p>\n<p>A report from Goldman Sachs shows how much of investors’ money is concentrated in only five high-flying stocks. And a screen of the biggest contributors to this year’s excellent performance for the S&P 500 index highlights two that are expected not to perform well in 2022: Apple and Tesla.</p>\n<p>Just five stocks — Microsoft Corp.,Alphabet Inc.,Apple Inc.,Nvidia Corp. and Tesla Inc. — contributed over a third of the S&P 500 Index’s 26% total return for 2021 through Dec. 9, according to analysts at Goldman. And from the end of April through Dec. 9, they contributed 51% of the index’s 13% return.</p>\n<p>Moreover, only 25 stocks accounted for 58% of the index’s gains, including reinvested dividends, through Dec. 9, Goldman said. Its list of those stocks is below, along with screens of Wall Street analysts’ expectations for the group as we look ahead to 2022 and 2023.</p>\n<p>The analysts, led by David Kostin, pointed out that “market breadth has narrowed substantially” over the past several months. In other words, investors have concentrated more of their money (and risk) in the largest tech companies, by market capitalization.</p>\n<p>That said, the Goldman analysts continue to recommend that long-term investors “own high-growth, high-margin stocks.”</p>\n<p><b>Digging into the 25 biggest contributors to the S&P 500’s returns this year</b></p>\n<p>This list shows each of the 25 stocks and their “contributions” to the gains, expressed in basis points. (A basis point is one 100th of a percent. ) The table also includes pricing information — closing prices as of Dec. 14 with declines from 52-week highs and the dates of those highs.</p>\n<table>\n <tbody>\n <tr>\n <td><b>Company</b></td>\n <td><b>Ticker</b></td>\n <td><b>Total return – 2021 through Dec. 9</b></td>\n <td><b>Contribution to S&P 500’s return for 2021 through Dec. 9 (basis points)</b></td>\n <td><b>Closing Price – 12/14/21</b></td>\n <td><b>Decline from 52-week high</b></td>\n <td><b>Date of 52-week high</b></td>\n </tr>\n <tr>\n <td>Microsoft Corp.</td>\n <td>MSFT</td>\n <td>51%</td>\n <td>271</td>\n <td>$328.34</td>\n <td>-6.1%</td>\n <td>11/22/2021</td>\n </tr>\n <tr>\n <td>Alphabet Inc. Class A</td>\n <td>GOOGL</td>\n <td>68%</td>\n <td>224</td>\n <td>$2,878.14</td>\n <td>-4.7%</td>\n <td>11/19/2021</td>\n </tr>\n <tr>\n <td>Apple Inc.</td>\n <td>AAPL</td>\n <td>32%</td>\n <td>217</td>\n <td>$174.33</td>\n <td>-4.3%</td>\n <td>12/13/2021</td>\n </tr>\n <tr>\n <td>Nvidia Corp.</td>\n <td>NVDA</td>\n <td>134%</td>\n <td>137</td>\n <td>$283.37</td>\n <td>-18.2%</td>\n <td>11/22/2021</td>\n </tr>\n <tr>\n <td>Tesla Inc.</td>\n <td>TSLA</td>\n <td>42%</td>\n <td>71</td>\n <td>$958.51</td>\n <td>-22.9%</td>\n <td>11/04/2021</td>\n </tr>\n <tr>\n <td>Home Depot Inc.</td>\n <td>HD</td>\n <td>58%</td>\n <td>52</td>\n <td>$402.20</td>\n <td>-4.4%</td>\n <td>12/06/2021</td>\n </tr>\n <tr>\n <td>Meta Platforms Inc. Class A</td>\n <td>FB</td>\n <td>21%</td>\n <td>43</td>\n <td>$333.74</td>\n <td>-13.2%</td>\n <td>09/01/2021</td>\n </tr>\n <tr>\n <td>UnitedHealth Group Inc.</td>\n <td>UNH</td>\n <td>37%</td>\n <td>39</td>\n <td>$479.46</td>\n <td>-0.7%</td>\n <td>12/14/2021</td>\n </tr>\n <tr>\n <td>Bank of America Corp</td>\n <td>BAC</td>\n <td>50%</td>\n <td>36</td>\n <td>$44.13</td>\n <td>-9.4%</td>\n <td>11/03/2021</td>\n </tr>\n <tr>\n <td>JPMorgan Chase & Co.</td>\n <td>JPM</td>\n <td>29%</td>\n <td>36</td>\n <td>$159.13</td>\n <td>-8.0%</td>\n <td>10/25/2021</td>\n </tr>\n <tr>\n <td>Exxon Mobil Corp.</td>\n <td>XOM</td>\n <td>61%</td>\n <td>34</td>\n <td>$61.54</td>\n <td>-7.3%</td>\n <td>11/08/2021</td>\n </tr>\n <tr>\n <td>Berkshire Hathaway Inc. Class B</td>\n <td>BRK</td>\n <td>23%</td>\n <td>32</td>\n <td>$295.03</td>\n <td>-0.5%</td>\n <td>12/14/2021</td>\n </tr>\n <tr>\n <td>Amazon.com Inc.</td>\n <td>AMZN</td>\n <td>7%</td>\n <td>31</td>\n <td>$3,381.83</td>\n <td>-10.4%</td>\n <td>07/13/2021</td>\n </tr>\n <tr>\n <td>Pfizer Inc.</td>\n <td>PFE</td>\n <td>47%</td>\n <td>30</td>\n <td>$55.54</td>\n <td>-0.7%</td>\n <td>12/14/2021</td>\n </tr>\n <tr>\n <td>Wells Fargo & Co.</td>\n <td>WFC</td>\n <td>67%</td>\n <td>26</td>\n <td>$48.89</td>\n <td>-7.0%</td>\n <td>11/03/2021</td>\n </tr>\n <tr>\n <td>Chevron Corp.</td>\n <td>CVX</td>\n <td>47%</td>\n <td>24</td>\n <td>$116.22</td>\n <td>-2.5%</td>\n <td>12/08/2021</td>\n </tr>\n <tr>\n <td>Intuit Inc.</td>\n <td>INTU</td>\n <td>76%</td>\n <td>24</td>\n <td>$639.48</td>\n <td>-10.8%</td>\n <td>11/19/2021</td>\n </tr>\n <tr>\n <td>Lowe’s Companies Inc.</td>\n <td><a href=\"https://www.marketwatch.com/investing/stock/LOW?mod=MW_story_quote\" target=\"_blank\">LOW</a></td>\n <td>63%</td>\n <td>23</td>\n <td>$252.46</td>\n <td>-4.1%</td>\n <td>12/13/2021</td>\n </tr>\n <tr>\n <td>Accenture Plc Class A</td>\n <td>ACN</td>\n <td>44%</td>\n <td>23</td>\n <td>$369.73</td>\n <td>-3.0%</td>\n <td>12/13/2021</td>\n </tr>\n <tr>\n <td>Thermo Fisher Scientific Inc.</td>\n <td>TMO</td>\n <td>37%</td>\n <td>22</td>\n <td>$632.11</td>\n <td>-5.2%</td>\n <td>11/26/2021</td>\n </tr>\n <tr>\n <td>Costco Wholesale Corp.</td>\n <td>COST</td>\n <td>40%</td>\n <td>21</td>\n <td>$545.34</td>\n <td>-2.8%</td>\n <td>12/10/2021</td>\n </tr>\n <tr>\n <td>Broadcom Inc.</td>\n <td>AVGO</td>\n <td>36%</td>\n <td>20</td>\n <td>$614.91</td>\n <td>-4.6%</td>\n <td>12/10/2021</td>\n </tr>\n <tr>\n <td>Adobe Inc.</td>\n <td>ADBE</td>\n <td>26%</td>\n <td>20</td>\n <td>$614.86</td>\n <td>-12.1%</td>\n <td>11/22/2021</td>\n </tr>\n <tr>\n <td>Danaher Corp.</td>\n <td>DHR</td>\n <td>44%</td>\n <td>20</td>\n <td>$307.70</td>\n <td>-7.9%</td>\n <td>09/10/2021</td>\n </tr>\n <tr>\n <td>Eli Lilly and Co.</td>\n <td>LLY</td>\n <td>46%</td>\n <td>19</td>\n <td>$249.38</td>\n <td>-9.6%</td>\n <td>08/17/2021</td>\n </tr>\n </tbody>\n</table>\n<p>Sources: Goldman Sachs, FactSet</p>\n<table>\n <tbody></tbody>\n</table>\n<p>We included the declines from 52-week highs through Dec. 14 to illustrate how volatile the stocks of rapidly growing tech giants can be. Shares of Nvidia, for example, were down 18% from the high reached Nov. 22. Tesla has tumbled into bear-market territory three times in 2021 and is down 23% from its high reached Nov. 4.</p>\n<p>Leaving the list in the same order, here are consensus estimates among analysts polled by FactSet for sales (in millions of dollars) for calendar years through 2023, with projected compound annual growth rates (CAGR):</p>\n<table>\n <tbody>\n <tr>\n <td><b>Company</b></td>\n <td><b>Ticker</b></td>\n <td><b>Estimated revenue – 2021</b></td>\n <td><b>Estimated revenue – 2022</b></td>\n <td><b>Estimated revenue – 2023</b></td>\n <td><b>Two-year estimated sales CAGR</b></td>\n </tr>\n <tr>\n <td>Microsoft Corp.</td>\n <td>MSFT</td>\n <td>$182,593</td>\n <td>$210,753</td>\n <td>$240,396</td>\n <td>14.7%</td>\n </tr>\n <tr>\n <td>Alphabet Inc. Class A</td>\n <td>GOOGL</td>\n <td>$254,060</td>\n <td>$296,677</td>\n <td>$341,671</td>\n <td>16.0%</td>\n </tr>\n <tr>\n <td>Apple Inc.</td>\n <td>AAPL</td>\n <td>$369,729</td>\n <td>$389,037</td>\n <td>$413,789</td>\n <td>5.8%</td>\n </tr>\n <tr>\n <td>Nvidia Corp.</td>\n <td>NVDA</td>\n <td>$25,754</td>\n <td>$31,175</td>\n <td>$36,380</td>\n <td>18.9%</td>\n </tr>\n <tr>\n <td>Tesla Inc.</td>\n <td>TSLA</td>\n <td>$51,678</td>\n <td>$73,183</td>\n <td>$89,639</td>\n <td>31.7%</td>\n </tr>\n <tr>\n <td>Home Depot Inc.</td>\n <td>HD</td>\n <td>$148,615</td>\n <td>$153,285</td>\n <td>$158,252</td>\n <td>3.2%</td>\n </tr>\n <tr>\n <td>Meta Platforms Inc. Class A</td>\n <td>FB</td>\n <td>$117,569</td>\n <td>$139,805</td>\n <td>$164,737</td>\n <td>18.4%</td>\n </tr>\n <tr>\n <td>UnitedHealth Group Inc.</td>\n <td>UNH</td>\n <td>$286,410</td>\n <td>$316,412</td>\n <td>$342,740</td>\n <td>9.4%</td>\n </tr>\n <tr>\n <td>Bank of America Corp</td>\n <td>BAC</td>\n <td>$89,268</td>\n <td>$93,591</td>\n <td>$99,180</td>\n <td>5.4%</td>\n </tr>\n <tr>\n <td>JPMorgan Chase & Co.</td>\n <td>JPM</td>\n <td>$123,128</td>\n <td>$123,405</td>\n <td>$130,270</td>\n <td>2.9%</td>\n </tr>\n <tr>\n <td>Exxon Mobil Corp.</td>\n <td>XOM</td>\n <td>$294,130</td>\n <td>$308,304</td>\n <td>$292,830</td>\n <td>-0.2%</td>\n </tr>\n <tr>\n <td>Berkshire Hathaway Inc. Class B</td>\n <td>BRK</td>\n <td>$294,667</td>\n <td>$294,894</td>\n <td>$309,287</td>\n <td>2.5%</td>\n </tr>\n <tr>\n <td>Amazon.com Inc.</td>\n <td>AMZN</td>\n <td>$470,607</td>\n <td>$553,097</td>\n <td>$649,246</td>\n <td>17.5%</td>\n </tr>\n <tr>\n <td>Pfizer Inc.</td>\n <td>PFE</td>\n <td>$81,333</td>\n <td>$92,070</td>\n <td>$72,748</td>\n <td>-5.4%</td>\n </tr>\n <tr>\n <td>Wells Fargo & Co.</td>\n <td>WFC</td>\n <td>$76,024</td>\n <td>$72,048</td>\n <td>$75,462</td>\n <td>-0.4%</td>\n </tr>\n <tr>\n <td>Chevron Corp.</td>\n <td>CVX</td>\n <td>$155,748</td>\n <td>$168,114</td>\n <td>$159,898</td>\n <td>1.3%</td>\n </tr>\n <tr>\n <td>Intuit Inc.</td>\n <td>INTU</td>\n <td>$10,714</td>\n <td>$12,980</td>\n <td>$14,881</td>\n <td>17.9%</td>\n </tr>\n <tr>\n <td>Lowe’s Companies Inc.</td>\n <td>LOW</td>\n <td>$95,152</td>\n <td>$97,459</td>\n <td>$100,080</td>\n <td>2.6%</td>\n </tr>\n <tr>\n <td>Accenture Plc Class A</td>\n <td>ACN</td>\n <td>$52,819</td>\n <td>$58,906</td>\n <td>$63,622</td>\n <td>9.8%</td>\n </tr>\n <tr>\n <td>Thermo Fisher Scientific Inc.</td>\n <td>TMO</td>\n <td>$37,210</td>\n <td>$39,493</td>\n <td>$42,053</td>\n <td>6.3%</td>\n </tr>\n <tr>\n <td>Costco Wholesale Corp.</td>\n <td>COST</td>\n <td>$203,027</td>\n <td>$222,877</td>\n <td>$238,794</td>\n <td>8.5%</td>\n </tr>\n <tr>\n <td>Broadcom Inc.</td>\n <td>AVGO</td>\n <td>$27,976</td>\n <td>$30,877</td>\n <td>$32,521</td>\n <td>7.8%</td>\n </tr>\n <tr>\n <td>Adobe Inc.</td>\n <td>ADBE</td>\n <td>$15,957</td>\n <td>$18,393</td>\n <td>$21,000</td>\n <td>14.7%</td>\n </tr>\n <tr>\n <td>Danaher Corp.</td>\n <td>DHR</td>\n <td>$29,116</td>\n <td>$30,792</td>\n <td>$32,437</td>\n <td>5.5%</td>\n </tr>\n <tr>\n <td>Eli Lilly and Co.</td>\n <td>LLY</td>\n <td>$27,601</td>\n <td>$27,774</td>\n <td>$30,366</td>\n <td>4.9%</td>\n </tr>\n </tbody>\n</table>\n<p>Source: FactSet</p>\n<p>Here’s another look ahead, this time at earnings-per-share estimates</p>\n<table>\n <tbody>\n <tr>\n <td><b>Company</b></td>\n <td><b>Ticker</b></td>\n <td><b>Estimated EPS – 2021</b></td>\n <td><b>Estimated EPS – 2022</b></td>\n <td><b>Estimated EPS – 2023</b></td>\n <td><b>Two-year estimated EPS CAGR</b></td>\n </tr>\n <tr>\n <td>Microsoft Corp.</td>\n <td>MSFT</td>\n <td>$8.60</td>\n <td>$9.85</td>\n <td>$11.44</td>\n <td>15.3%</td>\n </tr>\n <tr>\n <td>Alphabet Inc. Class A</td>\n <td>GOOGL</td>\n <td>$108.65</td>\n <td>$113.97</td>\n <td>$130.48</td>\n <td>9.6%</td>\n </tr>\n <tr>\n <td>Apple Inc.</td>\n <td>AAPL</td>\n <td>$5.64</td>\n <td>$5.85</td>\n <td>$6.27</td>\n <td>5.4%</td>\n </tr>\n <tr>\n <td>Nvidia Corp.</td>\n <td>NVDA</td>\n <td>$4.18</td>\n <td>$5.08</td>\n <td>$6.15</td>\n <td>21.3%</td>\n </tr>\n <tr>\n <td>Tesla Inc.</td>\n <td>TSLA</td>\n <td>$5.99</td>\n <td>$8.64</td>\n <td>$11.46</td>\n <td>38.3%</td>\n </tr>\n <tr>\n <td>Home Depot Inc.</td>\n <td>HD</td>\n <td>$15.17</td>\n <td>$16.13</td>\n <td>$17.30</td>\n <td>6.8%</td>\n </tr>\n <tr>\n <td>Meta Platforms Inc. Class A</td>\n <td>FB</td>\n <td>$13.94</td>\n <td>$14.24</td>\n <td>$16.94</td>\n <td>10.3%</td>\n </tr>\n <tr>\n <td>UnitedHealth Group Inc.</td>\n <td>UNH</td>\n <td>$18.84</td>\n <td>$21.63</td>\n <td>$24.58</td>\n <td>14.2%</td>\n </tr>\n <tr>\n <td>Bank of America Corp</td>\n <td>BAC</td>\n <td>$3.52</td>\n <td>$3.19</td>\n <td>$3.63</td>\n <td>1.5%</td>\n </tr>\n <tr>\n <td>JPMorgan Chase & Co.</td>\n <td>JPM</td>\n <td>$14.98</td>\n <td>$12.03</td>\n <td>$13.23</td>\n <td>-6.0%</td>\n </tr>\n <tr>\n <td>Exxon Mobil Corp.</td>\n <td>XOM</td>\n <td>$5.03</td>\n <td>$5.79</td>\n <td>$5.59</td>\n <td>5.4%</td>\n </tr>\n <tr>\n <td>Berkshire Hathaway Inc. Class B</td>\n <td>BRK</td>\n <td>$11.65</td>\n <td>$12.63</td>\n <td>$14.13</td>\n <td>10.1%</td>\n </tr>\n <tr>\n <td>Amazon.com Inc.</td>\n <td>AMZN</td>\n <td>$41.31</td>\n <td>$51.54</td>\n <td>$76.68</td>\n <td>36.2%</td>\n </tr>\n <tr>\n <td>Pfizer Inc.</td>\n <td>PFE</td>\n <td>$4.19</td>\n <td>$5.75</td>\n <td>$4.87</td>\n <td>7.8%</td>\n </tr>\n <tr>\n <td>Wells Fargo & Co.</td>\n <td>WFC</td>\n <td>$4.63</td>\n <td>$3.72</td>\n <td>$4.41</td>\n <td>-2.4%</td>\n </tr>\n <tr>\n <td>Chevron Corp.</td>\n <td>CVX</td>\n <td>$8.36</td>\n <td>$9.42</td>\n <td>$8.78</td>\n <td>2.5%</td>\n </tr>\n <tr>\n <td>Intuit Inc.</td>\n <td>INTU</td>\n <td>$10.56</td>\n <td>$12.51</td>\n <td>$14.70</td>\n <td>18.0%</td>\n </tr>\n <tr>\n <td>Lowe’s Companies Inc.</td>\n <td>LOW</td>\n <td>$11.71</td>\n <td>$12.86</td>\n <td>$14.40</td>\n <td>10.9%</td>\n </tr>\n <tr>\n <td>Accenture Plc Class A</td>\n <td>ACN</td>\n <td>$9.25</td>\n <td>$10.48</td>\n <td>$11.59</td>\n <td>11.9%</td>\n </tr>\n <tr>\n <td>Thermo Fisher Scientific Inc.</td>\n <td>TMO</td>\n <td>$23.45</td>\n <td>$21.17</td>\n <td>$23.34</td>\n <td>-0.2%</td>\n </tr>\n <tr>\n <td>Costco Wholesale Corp.</td>\n <td>COST</td>\n <td>$11.63</td>\n <td>$13.06</td>\n <td>$14.33</td>\n <td>11.0%</td>\n </tr>\n <tr>\n <td>Broadcom Inc.</td>\n <td>AVGO</td>\n <td>$28.83</td>\n <td>$33.53</td>\n <td>$36.69</td>\n <td>12.8%</td>\n </tr>\n <tr>\n <td>Adobe Inc.</td>\n <td>ADBE</td>\n <td>$12.63</td>\n <td>$14.47</td>\n <td>$16.88</td>\n <td>15.6%</td>\n </tr>\n <tr>\n <td>Danaher Corp.</td>\n <td>DHR</td>\n <td>$9.82</td>\n <td>$10.16</td>\n <td>$10.72</td>\n <td>4.5%</td>\n </tr>\n <tr>\n <td>Eli Lilly and Co.</td>\n <td>LLY</td>\n <td>$8.02</td>\n <td>$8.13</td>\n <td>$9.71</td>\n <td>10.1%</td>\n </tr>\n </tbody>\n</table>\n<p>Source: FactSet</p>\n<p>Here’s a summary of Wall Street analysts’ opinions about the stocks:</p>\n<table>\n <tbody>\n <tr>\n <td><b>Company</b></td>\n <td><b>Ticker</b></td>\n <td><b>Share “buy” ratings</b></td>\n <td><b>Share neutral ratings</b></td>\n <td><b>Share “sell” ratings</b></td>\n <td><b>Closing price – 12/14/21</b></td>\n <td><b>Consensus price target</b></td>\n <td><b>Implied 12-month upside potential</b></td>\n </tr>\n <tr>\n <td>Microsoft Corp.</td>\n <td>MSFT</td>\n <td>90%</td>\n <td>10%</td>\n <td>0%</td>\n <td>$328.34</td>\n <td>$366.41</td>\n <td>12%</td>\n </tr>\n <tr>\n <td>Alphabet Inc. Class A</td>\n <td>GOOGL</td>\n <td>94%</td>\n <td>6%</td>\n <td>0%</td>\n <td>$2,878.14</td>\n <td>$3,333.70</td>\n <td>16%</td>\n </tr>\n <tr>\n <td>Apple Inc.</td>\n <td>AAPL</td>\n <td>79%</td>\n <td>19%</td>\n <td>2%</td>\n <td>$174.33</td>\n <td>$174.35</td>\n <td>0%</td>\n </tr>\n <tr>\n <td>Nvidia Corp.</td>\n <td>NVDA</td>\n <td>81%</td>\n <td>12%</td>\n <td>7%</td>\n <td>$283.37</td>\n <td>$341.51</td>\n <td>21%</td>\n </tr>\n <tr>\n <td>Tesla Inc.</td>\n <td>TSLA</td>\n <td>43%</td>\n <td>30%</td>\n <td>28%</td>\n <td>$958.51</td>\n <td>$860.35</td>\n <td>-10%</td>\n </tr>\n <tr>\n <td>Home Depot Inc.</td>\n <td>HD</td>\n <td>65%</td>\n <td>32%</td>\n <td>3%</td>\n <td>$402.20</td>\n <td>$417.16</td>\n <td>4%</td>\n </tr>\n <tr>\n <td>Meta Platforms Inc. Class A</td>\n <td>FB</td>\n <td>76%</td>\n <td>22%</td>\n <td>2%</td>\n <td>$333.74</td>\n <td>$398.32</td>\n <td>19%</td>\n </tr>\n <tr>\n <td>UnitedHealth Group Inc.</td>\n <td>UNH</td>\n <td>85%</td>\n <td>11%</td>\n <td>4%</td>\n <td>$479.46</td>\n <td>$490.88</td>\n <td>2%</td>\n </tr>\n <tr>\n <td>Bank of America Corp</td>\n <td>BAC</td>\n <td>64%</td>\n <td>25%</td>\n <td>11%</td>\n <td>$44.13</td>\n <td>$49.83</td>\n <td>13%</td>\n </tr>\n <tr>\n <td>JPMorgan Chase & Co.</td>\n <td>JPM</td>\n <td>61%</td>\n <td>32%</td>\n <td>7%</td>\n <td>$159.13</td>\n <td>$179.70</td>\n <td>13%</td>\n </tr>\n <tr>\n <td>Exxon Mobil Corp.</td>\n <td>XOM</td>\n <td>39%</td>\n <td>51%</td>\n <td>10%</td>\n <td>$61.54</td>\n <td>$72.97</td>\n <td>19%</td>\n </tr>\n <tr>\n <td>Berkshire Hathaway Inc. Class B</td>\n <td>BRK</td>\n <td>43%</td>\n <td>57%</td>\n <td>0%</td>\n <td>$295.03</td>\n <td>$332.50</td>\n <td>13%</td>\n </tr>\n <tr>\n <td>Amazon.com Inc.</td>\n <td>AMZN</td>\n <td>94%</td>\n <td>6%</td>\n <td>0%</td>\n <td>$3,381.83</td>\n <td>$4,102.98</td>\n <td>21%</td>\n </tr>\n <tr>\n <td>Pfizer Inc.</td>\n <td>PFE</td>\n <td>38%</td>\n <td>58%</td>\n <td>4%</td>\n <td>$55.54</td>\n <td>$53.67</td>\n <td>-3%</td>\n </tr>\n <tr>\n <td>Wells Fargo & Co.</td>\n <td>WFC</td>\n <td>67%</td>\n <td>33%</td>\n <td>0%</td>\n <td>$48.89</td>\n <td>$54.90</td>\n <td>12%</td>\n </tr>\n <tr>\n <td>Chevron Corp.</td>\n <td>CVX</td>\n <td>68%</td>\n <td>32%</td>\n <td>0%</td>\n <td>$116.22</td>\n <td>$130.36</td>\n <td>12%</td>\n </tr>\n <tr>\n <td>Intuit Inc.</td>\n <td>INTU</td>\n <td>83%</td>\n <td>13%</td>\n <td>4%</td>\n <td>$639.48</td>\n <td>$756.29</td>\n <td>18%</td>\n </tr>\n <tr>\n <td>Lowe’s Companies Inc.</td>\n <td>LOW</td>\n <td>73%</td>\n <td>24%</td>\n <td>3%</td>\n <td>$252.46</td>\n <td>$272.43</td>\n <td>8%</td>\n </tr>\n <tr>\n <td>Accenture Plc Class A</td>\n <td>ACN</td>\n <td>70%</td>\n <td>26%</td>\n <td>4%</td>\n <td>$369.73</td>\n <td>$383.68</td>\n <td>4%</td>\n </tr>\n <tr>\n <td>Thermo Fisher Scientific Inc.</td>\n <td>TMO</td>\n <td>83%</td>\n <td>13%</td>\n <td>4%</td>\n <td>$632.11</td>\n <td>$682.47</td>\n <td>8%</td>\n </tr>\n <tr>\n <td>Costco Wholesale Corp.</td>\n <td>COST</td>\n <td>59%</td>\n <td>35%</td>\n <td>6%</td>\n <td>$545.34</td>\n <td>$551.75</td>\n <td>1%</td>\n </tr>\n <tr>\n <td>Broadcom Inc.</td>\n <td>AVGO</td>\n <td>84%</td>\n <td>13%</td>\n <td>3%</td>\n <td>$614.91</td>\n <td>$682.70</td>\n <td>11%</td>\n </tr>\n <tr>\n <td>Adobe Inc.</td>\n <td>ADBE</td>\n <td>81%</td>\n <td>19%</td>\n <td>0%</td>\n <td>$614.86</td>\n <td>$720.69</td>\n <td>17%</td>\n </tr>\n <tr>\n <td>Danaher Corp.</td>\n <td>DHR</td>\n <td>82%</td>\n <td>14%</td>\n <td>4%</td>\n <td>$307.70</td>\n <td>$350.29</td>\n <td>14%</td>\n </tr>\n <tr>\n <td>Eli Lilly and Co.</td>\n <td>LLY</td>\n <td>67%</td>\n <td>28%</td>\n <td>5%</td>\n <td>$249.38</td>\n <td>$279.72</td>\n <td>12%</td>\n </tr>\n </tbody>\n</table>\n<p>Source: FactSet</p>\n<p>Here are six data highlights to consider:</p>\n<ul>\n <li>Two of this year’s best performers are expected to be poor performers next year, based on the price targets: Apple and Tesla.</li>\n <li>Apple is expected to show much slower sales and earnings growth than the rest of the top five companies on the list through 2023.</li>\n <li>Tesla’s expected two-year sales CAGR of 31.7% is by far the highest on the list. But only 43% of analysts polled by FactSet rate the stock a “buy.”</li>\n <li>Tesla also has the highest expected EPS CAGR through 2023 at 38.3%, but Amazon.com Inc. is right behind, with a projected EPS CAGR of 36.2%. Next on the list by this measure is Nvidia, at 21.3%.</li>\n <li>From the price targets, Nvidia and Amazon are Wall Street analysts’ favorite stocks on the list, with implied 12-month upside of 21%.</li>\n <li>Pfizer Inc.’s sales are expected to rise in 2022 but fall in 2023 to a level below that of 2021, according to analysts polled by FactSet. That could reflect expectations that the coronavirus pandemic will be ending.</li>\n</ul>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After a dazzling 2021, Apple and Tesla stocks are expected to be duds in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter a dazzling 2021, Apple and Tesla stocks are expected to be duds in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 11:11 GMT+8 <a href=https://www.marketwatch.com/story/after-a-dazzling-2021-apple-and-tesla-stocks-are-expected-to-be-duds-in-2022-11639582194?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here’s the outlook for the 25 stocks that have contributed more than half of the S&P 500 index’s gain this year\nShares of Apple have returned 32% this year, while Tesla has risen 36%. Getty Images\nA ...</p>\n\n<a href=\"https://www.marketwatch.com/story/after-a-dazzling-2021-apple-and-tesla-stocks-are-expected-to-be-duds-in-2022-11639582194?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","BK4550":"红杉资本持仓","BK4099":"汽车制造商","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4555":"新能源车","MSFT":"微软","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","NVDA":"英伟达","AAPL":"苹果","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4501":"段永平概念","GOOGL":"谷歌A","TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/after-a-dazzling-2021-apple-and-tesla-stocks-are-expected-to-be-duds-in-2022-11639582194?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191399540","content_text":"Here’s the outlook for the 25 stocks that have contributed more than half of the S&P 500 index’s gain this year\nShares of Apple have returned 32% this year, while Tesla has risen 36%. Getty Images\nA report from Goldman Sachs shows how much of investors’ money is concentrated in only five high-flying stocks. And a screen of the biggest contributors to this year’s excellent performance for the S&P 500 index highlights two that are expected not to perform well in 2022: Apple and Tesla.\nJust five stocks — Microsoft Corp.,Alphabet Inc.,Apple Inc.,Nvidia Corp. and Tesla Inc. — contributed over a third of the S&P 500 Index’s 26% total return for 2021 through Dec. 9, according to analysts at Goldman. And from the end of April through Dec. 9, they contributed 51% of the index’s 13% return.\nMoreover, only 25 stocks accounted for 58% of the index’s gains, including reinvested dividends, through Dec. 9, Goldman said. Its list of those stocks is below, along with screens of Wall Street analysts’ expectations for the group as we look ahead to 2022 and 2023.\nThe analysts, led by David Kostin, pointed out that “market breadth has narrowed substantially” over the past several months. In other words, investors have concentrated more of their money (and risk) in the largest tech companies, by market capitalization.\nThat said, the Goldman analysts continue to recommend that long-term investors “own high-growth, high-margin stocks.”\nDigging into the 25 biggest contributors to the S&P 500’s returns this year\nThis list shows each of the 25 stocks and their “contributions” to the gains, expressed in basis points. (A basis point is one 100th of a percent. ) The table also includes pricing information — closing prices as of Dec. 14 with declines from 52-week highs and the dates of those highs.\n\n\n\nCompany\nTicker\nTotal return – 2021 through Dec. 9\nContribution to S&P 500’s return for 2021 through Dec. 9 (basis points)\nClosing Price – 12/14/21\nDecline from 52-week high\nDate of 52-week high\n\n\nMicrosoft Corp.\nMSFT\n51%\n271\n$328.34\n-6.1%\n11/22/2021\n\n\nAlphabet Inc. Class A\nGOOGL\n68%\n224\n$2,878.14\n-4.7%\n11/19/2021\n\n\nApple Inc.\nAAPL\n32%\n217\n$174.33\n-4.3%\n12/13/2021\n\n\nNvidia Corp.\nNVDA\n134%\n137\n$283.37\n-18.2%\n11/22/2021\n\n\nTesla Inc.\nTSLA\n42%\n71\n$958.51\n-22.9%\n11/04/2021\n\n\nHome Depot Inc.\nHD\n58%\n52\n$402.20\n-4.4%\n12/06/2021\n\n\nMeta Platforms Inc. Class A\nFB\n21%\n43\n$333.74\n-13.2%\n09/01/2021\n\n\nUnitedHealth Group Inc.\nUNH\n37%\n39\n$479.46\n-0.7%\n12/14/2021\n\n\nBank of America Corp\nBAC\n50%\n36\n$44.13\n-9.4%\n11/03/2021\n\n\nJPMorgan Chase & Co.\nJPM\n29%\n36\n$159.13\n-8.0%\n10/25/2021\n\n\nExxon Mobil Corp.\nXOM\n61%\n34\n$61.54\n-7.3%\n11/08/2021\n\n\nBerkshire Hathaway Inc. Class B\nBRK\n23%\n32\n$295.03\n-0.5%\n12/14/2021\n\n\nAmazon.com Inc.\nAMZN\n7%\n31\n$3,381.83\n-10.4%\n07/13/2021\n\n\nPfizer Inc.\nPFE\n47%\n30\n$55.54\n-0.7%\n12/14/2021\n\n\nWells Fargo & Co.\nWFC\n67%\n26\n$48.89\n-7.0%\n11/03/2021\n\n\nChevron Corp.\nCVX\n47%\n24\n$116.22\n-2.5%\n12/08/2021\n\n\nIntuit Inc.\nINTU\n76%\n24\n$639.48\n-10.8%\n11/19/2021\n\n\nLowe’s Companies Inc.\nLOW\n63%\n23\n$252.46\n-4.1%\n12/13/2021\n\n\nAccenture Plc Class A\nACN\n44%\n23\n$369.73\n-3.0%\n12/13/2021\n\n\nThermo Fisher Scientific Inc.\nTMO\n37%\n22\n$632.11\n-5.2%\n11/26/2021\n\n\nCostco Wholesale Corp.\nCOST\n40%\n21\n$545.34\n-2.8%\n12/10/2021\n\n\nBroadcom Inc.\nAVGO\n36%\n20\n$614.91\n-4.6%\n12/10/2021\n\n\nAdobe Inc.\nADBE\n26%\n20\n$614.86\n-12.1%\n11/22/2021\n\n\nDanaher Corp.\nDHR\n44%\n20\n$307.70\n-7.9%\n09/10/2021\n\n\nEli Lilly and Co.\nLLY\n46%\n19\n$249.38\n-9.6%\n08/17/2021\n\n\n\nSources: Goldman Sachs, FactSet\n\n\n\nWe included the declines from 52-week highs through Dec. 14 to illustrate how volatile the stocks of rapidly growing tech giants can be. Shares of Nvidia, for example, were down 18% from the high reached Nov. 22. Tesla has tumbled into bear-market territory three times in 2021 and is down 23% from its high reached Nov. 4.\nLeaving the list in the same order, here are consensus estimates among analysts polled by FactSet for sales (in millions of dollars) for calendar years through 2023, with projected compound annual growth rates (CAGR):\n\n\n\nCompany\nTicker\nEstimated revenue – 2021\nEstimated revenue – 2022\nEstimated revenue – 2023\nTwo-year estimated sales CAGR\n\n\nMicrosoft Corp.\nMSFT\n$182,593\n$210,753\n$240,396\n14.7%\n\n\nAlphabet Inc. Class A\nGOOGL\n$254,060\n$296,677\n$341,671\n16.0%\n\n\nApple Inc.\nAAPL\n$369,729\n$389,037\n$413,789\n5.8%\n\n\nNvidia Corp.\nNVDA\n$25,754\n$31,175\n$36,380\n18.9%\n\n\nTesla Inc.\nTSLA\n$51,678\n$73,183\n$89,639\n31.7%\n\n\nHome Depot Inc.\nHD\n$148,615\n$153,285\n$158,252\n3.2%\n\n\nMeta Platforms Inc. Class A\nFB\n$117,569\n$139,805\n$164,737\n18.4%\n\n\nUnitedHealth Group Inc.\nUNH\n$286,410\n$316,412\n$342,740\n9.4%\n\n\nBank of America Corp\nBAC\n$89,268\n$93,591\n$99,180\n5.4%\n\n\nJPMorgan Chase & Co.\nJPM\n$123,128\n$123,405\n$130,270\n2.9%\n\n\nExxon Mobil Corp.\nXOM\n$294,130\n$308,304\n$292,830\n-0.2%\n\n\nBerkshire Hathaway Inc. Class B\nBRK\n$294,667\n$294,894\n$309,287\n2.5%\n\n\nAmazon.com Inc.\nAMZN\n$470,607\n$553,097\n$649,246\n17.5%\n\n\nPfizer Inc.\nPFE\n$81,333\n$92,070\n$72,748\n-5.4%\n\n\nWells Fargo & Co.\nWFC\n$76,024\n$72,048\n$75,462\n-0.4%\n\n\nChevron Corp.\nCVX\n$155,748\n$168,114\n$159,898\n1.3%\n\n\nIntuit Inc.\nINTU\n$10,714\n$12,980\n$14,881\n17.9%\n\n\nLowe’s Companies Inc.\nLOW\n$95,152\n$97,459\n$100,080\n2.6%\n\n\nAccenture Plc Class A\nACN\n$52,819\n$58,906\n$63,622\n9.8%\n\n\nThermo Fisher Scientific Inc.\nTMO\n$37,210\n$39,493\n$42,053\n6.3%\n\n\nCostco Wholesale Corp.\nCOST\n$203,027\n$222,877\n$238,794\n8.5%\n\n\nBroadcom Inc.\nAVGO\n$27,976\n$30,877\n$32,521\n7.8%\n\n\nAdobe Inc.\nADBE\n$15,957\n$18,393\n$21,000\n14.7%\n\n\nDanaher Corp.\nDHR\n$29,116\n$30,792\n$32,437\n5.5%\n\n\nEli Lilly and Co.\nLLY\n$27,601\n$27,774\n$30,366\n4.9%\n\n\n\nSource: FactSet\nHere’s another look ahead, this time at earnings-per-share estimates\n\n\n\nCompany\nTicker\nEstimated EPS – 2021\nEstimated EPS – 2022\nEstimated EPS – 2023\nTwo-year estimated EPS CAGR\n\n\nMicrosoft Corp.\nMSFT\n$8.60\n$9.85\n$11.44\n15.3%\n\n\nAlphabet Inc. Class A\nGOOGL\n$108.65\n$113.97\n$130.48\n9.6%\n\n\nApple Inc.\nAAPL\n$5.64\n$5.85\n$6.27\n5.4%\n\n\nNvidia Corp.\nNVDA\n$4.18\n$5.08\n$6.15\n21.3%\n\n\nTesla Inc.\nTSLA\n$5.99\n$8.64\n$11.46\n38.3%\n\n\nHome Depot Inc.\nHD\n$15.17\n$16.13\n$17.30\n6.8%\n\n\nMeta Platforms Inc. Class A\nFB\n$13.94\n$14.24\n$16.94\n10.3%\n\n\nUnitedHealth Group Inc.\nUNH\n$18.84\n$21.63\n$24.58\n14.2%\n\n\nBank of America Corp\nBAC\n$3.52\n$3.19\n$3.63\n1.5%\n\n\nJPMorgan Chase & Co.\nJPM\n$14.98\n$12.03\n$13.23\n-6.0%\n\n\nExxon Mobil Corp.\nXOM\n$5.03\n$5.79\n$5.59\n5.4%\n\n\nBerkshire Hathaway Inc. Class B\nBRK\n$11.65\n$12.63\n$14.13\n10.1%\n\n\nAmazon.com Inc.\nAMZN\n$41.31\n$51.54\n$76.68\n36.2%\n\n\nPfizer Inc.\nPFE\n$4.19\n$5.75\n$4.87\n7.8%\n\n\nWells Fargo & Co.\nWFC\n$4.63\n$3.72\n$4.41\n-2.4%\n\n\nChevron Corp.\nCVX\n$8.36\n$9.42\n$8.78\n2.5%\n\n\nIntuit Inc.\nINTU\n$10.56\n$12.51\n$14.70\n18.0%\n\n\nLowe’s Companies Inc.\nLOW\n$11.71\n$12.86\n$14.40\n10.9%\n\n\nAccenture Plc Class A\nACN\n$9.25\n$10.48\n$11.59\n11.9%\n\n\nThermo Fisher Scientific Inc.\nTMO\n$23.45\n$21.17\n$23.34\n-0.2%\n\n\nCostco Wholesale Corp.\nCOST\n$11.63\n$13.06\n$14.33\n11.0%\n\n\nBroadcom Inc.\nAVGO\n$28.83\n$33.53\n$36.69\n12.8%\n\n\nAdobe Inc.\nADBE\n$12.63\n$14.47\n$16.88\n15.6%\n\n\nDanaher Corp.\nDHR\n$9.82\n$10.16\n$10.72\n4.5%\n\n\nEli Lilly and Co.\nLLY\n$8.02\n$8.13\n$9.71\n10.1%\n\n\n\nSource: FactSet\nHere’s a summary of Wall Street analysts’ opinions about the stocks:\n\n\n\nCompany\nTicker\nShare “buy” ratings\nShare neutral ratings\nShare “sell” ratings\nClosing price – 12/14/21\nConsensus price target\nImplied 12-month upside potential\n\n\nMicrosoft Corp.\nMSFT\n90%\n10%\n0%\n$328.34\n$366.41\n12%\n\n\nAlphabet Inc. Class A\nGOOGL\n94%\n6%\n0%\n$2,878.14\n$3,333.70\n16%\n\n\nApple Inc.\nAAPL\n79%\n19%\n2%\n$174.33\n$174.35\n0%\n\n\nNvidia Corp.\nNVDA\n81%\n12%\n7%\n$283.37\n$341.51\n21%\n\n\nTesla Inc.\nTSLA\n43%\n30%\n28%\n$958.51\n$860.35\n-10%\n\n\nHome Depot Inc.\nHD\n65%\n32%\n3%\n$402.20\n$417.16\n4%\n\n\nMeta Platforms Inc. Class A\nFB\n76%\n22%\n2%\n$333.74\n$398.32\n19%\n\n\nUnitedHealth Group Inc.\nUNH\n85%\n11%\n4%\n$479.46\n$490.88\n2%\n\n\nBank of America Corp\nBAC\n64%\n25%\n11%\n$44.13\n$49.83\n13%\n\n\nJPMorgan Chase & Co.\nJPM\n61%\n32%\n7%\n$159.13\n$179.70\n13%\n\n\nExxon Mobil Corp.\nXOM\n39%\n51%\n10%\n$61.54\n$72.97\n19%\n\n\nBerkshire Hathaway Inc. Class B\nBRK\n43%\n57%\n0%\n$295.03\n$332.50\n13%\n\n\nAmazon.com Inc.\nAMZN\n94%\n6%\n0%\n$3,381.83\n$4,102.98\n21%\n\n\nPfizer Inc.\nPFE\n38%\n58%\n4%\n$55.54\n$53.67\n-3%\n\n\nWells Fargo & Co.\nWFC\n67%\n33%\n0%\n$48.89\n$54.90\n12%\n\n\nChevron Corp.\nCVX\n68%\n32%\n0%\n$116.22\n$130.36\n12%\n\n\nIntuit Inc.\nINTU\n83%\n13%\n4%\n$639.48\n$756.29\n18%\n\n\nLowe’s Companies Inc.\nLOW\n73%\n24%\n3%\n$252.46\n$272.43\n8%\n\n\nAccenture Plc Class A\nACN\n70%\n26%\n4%\n$369.73\n$383.68\n4%\n\n\nThermo Fisher Scientific Inc.\nTMO\n83%\n13%\n4%\n$632.11\n$682.47\n8%\n\n\nCostco Wholesale Corp.\nCOST\n59%\n35%\n6%\n$545.34\n$551.75\n1%\n\n\nBroadcom Inc.\nAVGO\n84%\n13%\n3%\n$614.91\n$682.70\n11%\n\n\nAdobe Inc.\nADBE\n81%\n19%\n0%\n$614.86\n$720.69\n17%\n\n\nDanaher Corp.\nDHR\n82%\n14%\n4%\n$307.70\n$350.29\n14%\n\n\nEli Lilly and Co.\nLLY\n67%\n28%\n5%\n$249.38\n$279.72\n12%\n\n\n\nSource: FactSet\nHere are six data highlights to consider:\n\nTwo of this year’s best performers are expected to be poor performers next year, based on the price targets: Apple and Tesla.\nApple is expected to show much slower sales and earnings growth than the rest of the top five companies on the list through 2023.\nTesla’s expected two-year sales CAGR of 31.7% is by far the highest on the list. But only 43% of analysts polled by FactSet rate the stock a “buy.”\nTesla also has the highest expected EPS CAGR through 2023 at 38.3%, but Amazon.com Inc. is right behind, with a projected EPS CAGR of 36.2%. Next on the list by this measure is Nvidia, at 21.3%.\nFrom the price targets, Nvidia and Amazon are Wall Street analysts’ favorite stocks on the list, with implied 12-month upside of 21%.\nPfizer Inc.’s sales are expected to rise in 2022 but fall in 2023 to a level below that of 2021, according to analysts polled by FactSet. That could reflect expectations that the coronavirus pandemic will be ending.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604554222,"gmtCreate":1639427105057,"gmtModify":1639427105291,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604554222","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohunote.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602622586,"gmtCreate":1639017219120,"gmtModify":1639017219279,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Keep going 👍","listText":"Keep going 👍","text":"Keep going 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602622586","repostId":"1161444269","repostType":4,"repost":{"id":"1161444269","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638977215,"share":"https://www.laohunote.com/m/news/1161444269?lang=&edition=full","pubTime":"2021-12-08 23:26","market":"us","language":"en","title":"Apple shares rose nearly 2% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1161444269","media":"Tiger Newspress","summary":"Apple shares rose nearly 2% to a new high in morning trading.","content":"<p>Apple shares rose nearly 2% to a new high in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/9a9f5fdc1cb0a898675c515a39de7611\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose nearly 2% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose nearly 2% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose nearly 2% to a new high in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/9a9f5fdc1cb0a898675c515a39de7611\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161444269","content_text":"Apple shares rose nearly 2% to a new high in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602927185,"gmtCreate":1638961415614,"gmtModify":1638961899363,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Up and down","listText":"Up and down","text":"Up and down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602927185","repostId":"1136716851","repostType":4,"repost":{"id":"1136716851","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638955203,"share":"https://www.laohunote.com/m/news/1136716851?lang=&edition=full","pubTime":"2021-12-08 17:20","market":"us","language":"en","title":"Some Vaccine stocks corrected in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1136716851","media":"Tiger Newspress","summary":"Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell betwe","content":"<p>Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell between 3% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/b5fc2db6a961be0363c3be880585ad0f\" tg-width=\"404\" tg-height=\"241\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some Vaccine stocks corrected in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome Vaccine stocks corrected in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell between 3% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/b5fc2db6a961be0363c3be880585ad0f\" tg-width=\"404\" tg-height=\"241\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136716851","content_text":"Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell between 3% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1470,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606180012,"gmtCreate":1638842620747,"gmtModify":1638842643789,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Great 👍","listText":"Great 👍","text":"Great 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606180012","repostId":"1189410190","repostType":4,"repost":{"id":"1189410190","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638804387,"share":"https://www.laohunote.com/m/news/1189410190?lang=&edition=full","pubTime":"2021-12-06 23:26","market":"us","language":"en","title":"Stocks linked to the reopening of the economy gained on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1189410190","media":"Tiger Newspress","summary":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book","content":"<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks linked to the reopening of the economy gained on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks linked to the reopening of the economy gained on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189410190","content_text":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603502188,"gmtCreate":1638421108863,"gmtModify":1638421109139,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"🤔","listText":"🤔","text":"🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603502188","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohunote.com/m/news/1119742422?lang=&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p>\n<p>COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p>\n<p>The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p>\n<p>Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p>\n<p><b>Wall Street is neutral on Moderna</b></p>\n<p>Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p>\n<p>The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p>\n<p>Morgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p>\n<p><b>Pfizer: moderate buy, but experts are skeptical</b></p>\n<p>Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p>\n<p>JPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p>\n<p>The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p>\n<p><b>Wall Street Memes’ take</b></p>\n<p>COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p>\n<p>Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p>\n<p>Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads? </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads? \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 22:21 GMT+8 <a href=https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1916,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609723208,"gmtCreate":1638328751329,"gmtModify":1638328751421,"author":{"id":"4087362605261610","authorId":"4087362605261610","name":"ahoon","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087362605261610","authorIdStr":"4087362605261610"},"themes":[],"htmlText":"Hopefully both vaccine can work","listText":"Hopefully both vaccine can work","text":"Hopefully both vaccine can work","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609723208","repostId":"1176161322","repostType":4,"repost":{"id":"1176161322","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638263039,"share":"https://www.laohunote.com/m/news/1176161322?lang=&edition=full","pubTime":"2021-11-30 17:03","market":"us","language":"en","title":"Moderna stock slid 1.5% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1176161322","media":"Tiger Newspress","summary":"Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective agai","content":"<p>Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective against Omicron.</p>\n<p><img src=\"https://static.tigerbbs.com/dba337733c64956ca75b06171ffc5745\" tg-width=\"851\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p>\n<p>The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p>Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.</p>\n<p>Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.</p>\n<p>He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.</p>\n<p>Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock slid 1.5% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock slid 1.5% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective against Omicron.</p>\n<p><img src=\"https://static.tigerbbs.com/dba337733c64956ca75b06171ffc5745\" tg-width=\"851\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p>\n<p>The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p>Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.</p>\n<p>Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.</p>\n<p>He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.</p>\n<p>Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176161322","content_text":"Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective against Omicron.\n\nThe head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nVaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.\nBancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.\nHe had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.\nFear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}